Microbiota and enteric nervous system crosstalk in diabetic gastroenteropathy: bridging mechanistic insights to microbiome-based therapies
Open accessThe DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus has emerged as a global public health crisis, with over half of patients experiencing gastrointestinal (GI) symptoms that exacerbate glucose fluctuations and impair quality of life. While prior research on the pathophysiology of diabetic gastroenteropathy (DGE) focused primarily on autonomic neuropathy, particularly involving the vagus nerve, recent studies have shifted toward the impairment of the enteric nervous system (ENS). As the largest autonomous neural network governing GI motility independent of central control, structural and functional abnormalities of the ENS constitute the fundamental pathological basis for DGE. This review first delineates gut microbial alterations in diabetes and mechanisms by which dysbiosis compromises the integrity of the ENS. Second, we analyze how microbiota-derived metabolites (short-chain fatty acids, bile acids, tryptophan), gut hormones (glucagon-like peptide-1, ghrelin), and neurotransmitters (acetylcholine, vasoactive intestinal peptide, nitric oxide) multitarget the ENS—collectively establishing the “microbiota-ENS axis” as the central hub for GI sensorimotor control. Finally, we provide an overview of preclinical and clinical evidence for microbiome-targeted therapies (probiotics, prebiotics, fecal microbiota transplantation) in alleviating DGE symptoms and repairing ENS while outlining translational challenges and future research priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These microbiota-related changes may also help explain the frequent overlap between upper and lower gastrointestinal symptoms, including the coexistence of constipation and gastroparetic complaints [43, 48].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alterations in gut microbial composition may contribute to low-grade inflammation, barrier disfunction, and altered gut-brain signaling, influencing both gastric motility and symptom perception [46–48].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109119 · Cited by 10,123 · cited 1×
“Diabetes has become a global public health crisis, with epidemiological data revealing a prevalence of 10.5% among individuals aged 20 – 70 years, projected to climb to 12.2% by 2045 (Sun et al., 2021).”
InfluentialRinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the gut microbiota is initially established at birth, it evolves dynamically throughout life, modulated by host age, dietary patterns, and physical activity (Rinninella et al., 2019).”
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Formation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028
Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 1×
“Probiotics, prebiotics, and synbiotics have been shown in extensive clinical studies (Markowiak and S ́ liz ̇ ewska, 2017; Quigley, 2019; Mokkala et al., 2021; Wang et al., 2022a) to effectively treat gastrointestinal disorders, like functional dyspepsia, IBS, and chronic constipation, as well as…”
The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., & Balamurugan, R. (2020) · Nutrients · doi:10.3390/nu12051474 · Cited by 2,335 · cited 1×
“Magne et al. (2020). attribute these discrepancies to methodological heterogeneity, including variations in sample size, participant characteristics, and sequencing approaches (16S rRNA vs. metagenomics).”
Pattern recognition receptors in health and diseases
Li, D., & Wu, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00687-0 · Cited by 1,787 · cited 1×
“Additionally, TLRs recognize pathogen-associated molecular patterns and interfere with ENS signal transmission by detecting pathogen-associated molecular patterns (PAMPs) such as LPS and lipoproteins (Li and Wu, 2021).”
Role of gut microbiota in type 2 diabetes pathophysiology
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D. B., Morgun, A., & Shulzhenko, N. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.051 · Cited by 1,708
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., & Scaldaferri, F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03374-w · Cited by 1,498
The pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398 · cited 1×
“At the clinical application level, microbial therapies still face multiple challenges (Suez et al., 2019).”
Reigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
GABA-modulating bacteria of the human gut microbiota
Strandwitz, P., Kim, K. H., Terekhova, D., Liu, J. K., Sharma, A., Levering, J., McDonald, D., Dietrich, D., Ramadhar, T. R., Lekbua, A., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0307-3 · Cited by 1,170 · cited 1×
“In diabetic states, reduced abundance of these genera leads to weakened GABAergic signaling, impairing ENS regulation of intestinal motility and mucosal secretion (Strandwitz et al., 2019; Konstanti et al., 2024).”
Koliada, A., Syzenko, G., Moseiko, V., Budovska, L., Puchkov, K., Perederiy, V., Gavalko, Y., Dorofeyev, A., Romanenko, M., Tkach, S., et al. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1027-1 · Cited by 1,000
Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942 · cited 1×
“As evidenced in db/db and ob/ob mouse models (Thaiss et al., 2018), sustained hyperglycemia activates intestinal epithelial glucose transporter 2 (GLUT2) and downregulates the expression of zonula occludens-1 (ZO-1), increasing intestinal permeability.”
Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
Elshaghabee, F. M. F., Rokana, N., Gulhane, R. D., Sharma, C., & Panwar, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01490 · Cited by 940 · cited 1×
“Long-term supplementation of single strains may reduce native microbiota diversity and exacerbate intestinal dysbiosis (Elshaghabee et al., 2017).”
Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736
de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2017) · Diabetes Care · doi:10.2337/dc16-1324 · Cited by 704
So, D., Whelan, K., Rossi, M., Morrison, M., Holtmann, G., Kelly, J. T., Shanahan, E. R., Staudacher, H. M., & Campbell, K. L. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy041 · Cited by 683
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674
Toward a Wiring Diagram Understanding of Appetite Control
Andermann, M. L., & Lowell, B. B. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.014 · Cited by 606
De Vadder, F., Grasset, E., Mannerås Holm, L., Karsenty, G., Macpherson, A. J., Olofsson, L. E., & Bäckhed, F. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720017115 · Cited by 566
Short-Chain Fatty Acids Regulate the Enteric Neurons and Control Gastrointestinal Motility in Rats
Soret, R., Chevalier, J., De Coppet, P., Poupeau, G., Derkinderen, P., Segain, J. P., & Neunlist, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.053 · Cited by 530
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L. M., Krämer, M., Gummesson, A., Perkins, R., Bergström, G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.011 · Cited by 528
Prebiotics: why definitions matter
Hutkins, R. W., Krumbeck, J. A., Bindels, L. B., Cani, P. D., Fahey, G., Goh, Y. J., Hamaker, B., Martens, E. C., Mills, D. A., Rastal, R. A., et al. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.09.001 · Cited by 437
Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis
Pinart, M., Dötsch, A., Schlicht, K., Laudes, M., Bouwman, J., Forslund, S. K., Pischon, T., & Nimptsch, K. (2021) · Nutrients · doi:10.3390/nu14010012 · Cited by 398 · cited 4×
“…obesity-associated free fatty acid (FFA) and bile acid dysmetabolism selectively suppress SCFA-producing bacteria, including Bi fi dobacterium , Faecalibacterium prausnitzii , and Roseburia , while promoting opportunistic pathogens such as Clostridium and Streptococcus (Pinart et al., 2021).”
InfluentialGut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling
Anitha, M., Vijay–Kumar, M., Sitaraman, S. V., Gewirtz, A. T., & Srinivasan, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.034 · Cited by 397
You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
Moszak, M., Szulińska, M., & Bogdański, P. (2020) · Nutrients · doi:10.3390/nu12041096 · Cited by 397
Kulich, K. R., Madisch, A., Pacini, F., Piqué, J. M., Regula, J., Van Rensburg, C. J., Újszászy, L., Carlsson, J., Halling, K., & Wiklund, I. K. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-12 · Cited by 396
Hvas, C. L., Dahl Jørgensen, S. M., Jørgensen, S. P., Storgaard, M., Lemming, L., Hansen, M. M., Erikstrup, C., & Dahlerup, J. F. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.019 · Cited by 390
Sharkey, K. A., & Mawe, G. M. (2023) · Physiological Reviews · doi:10.1152/physrev.00018.2022 · Cited by 390
Revicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01612.x · Cited by 383
Prebiotics and Probiotics in Digestive Health
Quigley, E. M. M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.028 · Cited by 380 · cited 1×
“Probiotics, prebiotics, and synbiotics have been shown in extensive clinical studies (Markowiak and S ́ liz ̇ ewska, 2017; Quigley, 2019; Mokkala et al., 2021; Wang et al., 2022a) to effectively treat gastrointestinal disorders, like functional dyspepsia, IBS, and chronic constipation, as well as…”
Brighton, C. A., Rievaj, J., Kuhre, R. E., Glass, L. L., Schoonjans, K., Holst, J. J., Gribble, F. M., & Reimann, F. (2015) · Endocrinology · doi:10.1210/en.2015-1321 · Cited by 355
Neuronal programming by microbiota regulates intestinal physiology
Obata, Y., Castaño, Á., Boeing, S., Bon-Frauches, A. C., Fung, C., Fallesen, T., de Agüero, M. G., Yilmaz, B., Lopes, R., Huseynova, A., et al. (2020) · Nature · doi:10.1038/s41586-020-1975-8 · Cited by 352 · cited 1×
“Notably, both dysbiosis and 5-HT de fi ciency impair AHR-mediated ENS regulation (Obata et al., 2020).”
Clinical Application and Potential of Fecal Microbiota Transplantation
Ooijevaar, R. E., Terveer, E. M., Verspaget, H. W., Kuijper, E. J., & Keller, J. J. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-111717-122956 · Cited by 336
Metabolic endotoxemia and diabetes mellitus: A systematic review
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus
Zhou, Z., Sun, B., Yu, D., & Zhu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.834485 · Cited by 327 · cited 2×
“A growing body of evidence (Wu et al., 2020; Zhao et al., 2020b; Zhou et al., 2022) reveals markedly altered abundance and diversity of gut microbiota in patients with diabetes compared to healthy individuals, characterized by low-diversity dysbiosis and an overgrowth of opportunistic pathogens.”
Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia
Vicentini, F. A., Keenan, C. M., Wallace, L. E., Woods, C., Cavin, J.-B., Flockton, A. R., Macklin, W. B., Belkind-Gerson, J., Hirota, S. A., & Sharkey, K. A. (2021) · Microbiome · doi:10.1186/s40168-021-01165-z · Cited by 326 · cited 1×
“Secondly, neuroprotective: SCFAs attenuate antibiotic-induced neuronal loss and regulate the survival of enteric neurons (Vicentini et al., 2021).”
Targeting the alternative bile acid synthetic pathway for metabolic diseases
Jia, W., Wei, M., Rajani, C., & Zheng, X. (2021) · Protein & Cell · doi:10.1007/s13238-020-00804-9 · Cited by 325
de Groot, P., Nikolic, T., Pellegrini, S., Sordi, V., Imangaliyev, S., Rampanelli, E., Hanssen, N., Attaye, I., Bakker, G., Duinkerken, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322630 · Cited by 316 · cited 4×
“Beyond neuromodulation, VIP maintains intestinal immune homeostasis by regulating T-cell responses and TLR signaling, demonstrating therapeutic potential in neuroimmune disorders like T1DM and irritable bowel syndrome (Iwasaki et al., 2019).”
InfluentialGABA and GABA receptors in the gastrointestinal tract: from motility to inflammation
Auteri, M., Zizzo, M. G., & Serio, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2014.12.001 · Cited by 307 · cited 1×
“…release, while GABA_B receptors promote contraction by enhancing cholinergic signaling; in the duodenum, GABA_A receptors are involved in releasing ACh, and GABA_C receptors are associated with releasing NO (Tonini et al., 1989; Zizzo et al., 2007; Rotondo et al., 2010; Auteri et al., 2014, 2015).”
Brun, P., Giron, M. C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., Banzato, S., Grillo, A. R., Spagnol, L., De Caro, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.047 · Cited by 300
Grasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J. E., Tercé, F., & Burcelin, R. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.013 · Cited by 281
Nøhr, M. K., Egerod, K. L., Christiansen, S. H., Gille, A., Offermanns, S., Schwartz, T. W., & Møller, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.040 · Cited by 266
Attaluri, A., Jackson, M., Valestin, J., & Rao, S. S. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.655 · Cited by 261
The neurobiology of irritable bowel syndrome
Mayer, E. A., Ryu, H. J., & Bhatt, R. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01972-w · Cited by 257
Bharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Ng, S. C., Xu, Z., Mak, J. W. Y., Yang, K., Liu, Q., Zuo, T., Tang, W., Lau, L., Lui, R. N., Wong, S. H., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-323617 · Cited by 249
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology
Saulnier, D. M., Ringel, Y., Heyman, M. B., Foster, J. A., Bercik, P., Shulman, R. J., Versalovic, J., Verdu, E. F., Dinan, T. G., Hecht, G., et al. (2013) · Gut Microbes · doi:10.4161/gmic.22973 · Cited by 248
Otaru, N., Ye, K., Mujezinovic, D., Berchtold, L., Constancias, F., Cornejo, F. A., Krzystek, A., de Wouters, T., Braegger, C., Lacroix, C., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.656895 · Cited by 243 · cited 2×
“Gut microbiota represents an important source of GABA; genera such as Bacteroides , Lactobacillus , and Levilactobacillus brevis directly secrete GABA by encoding glutamate decarboxylase (GAD), a key enzyme in GABA synthesis (Banerjee et al., 2021; Otaru et al., 2021).”
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Campbell, C., Kandalgaonkar, M. R., Golonka, R. M., Yeoh, B. S., Vijay-Kumar, M., & Saha, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020294 · Cited by 243
Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity
Sen, T., Cawthon, C. R., Ihde, B. T., Hajnal, A., DiLorenzo, P. M., de La Serre, C. B., & Czaja, K. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.02.027 · Cited by 239
Probiotics in Disease Prevention and Treatment
Liu, Y., Tran, D. Q., & Rhoads, J. M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1121 · Cited by 231 · cited 1×
“…live non-pathogenic microorganisms that confer bene fi cial effects when consumed in adequate amounts, probiotics primarily include genera such as Lactobacillus, Bi fi dobacterium, Bacillus , and Saccharomyces , which exist in forms like fermented foods and enteric-coated capsules (Liu et al., 2018).”
Poole, D. P., Godfrey, C., Cattaruzza, F., Cottrell, G. S., Kirkland, J. G., Pelayo, J. C., Bunnett, N. W., & Corvera, C. U. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01487.x · Cited by 228
Novel nano-encapsulated probiotic agents: Encapsulate materials, delivery, and encapsulation systems
Xu, C., Ban, Q., Wang, W., Hou, J., & Jiang, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.061 · Cited by 225 · cited 1×
“Currently, several innovative strategies are being investigated, including the use of bio fi lms and nanocoating for “ nano armor ” (Xu et al., 2022), single-cell technology-based “ armored probiotics ” (Zhao et al., 2024), targeted delivery systems (Li and Zhang, 2024), and encapsulating probiotics…”
Effect of Dietary Protein and Processing on Gut Microbiota—A Systematic Review
Wu, S., Bhat, Z., Gounder, R., Mohamed Ahmed, I., Al-Juhaimi, F., Ding, Y., & Bekhit, A. (2022) · Nutrients · doi:10.3390/nu14030453 · Cited by 223
Short-chain fatty acids suppress food intake by activating vagal afferent neurons
Goswami, C., Iwasaki, Y., & Yada, T. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.009 · Cited by 216 · cited 1×
“Thirdly, hormone regulation: Acting via vagal afferents or free fatty acid receptor 2/3 (FFAR2/FFAR3) activation on enteroendocrine cells, SCFAs stimulate secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), suppressing appetite and delaying gastric emptying (Goswami et al., 2018).”
Simon, E., Călinoiu, L. F., Mitrea, L., & Vodnar, D. C. (2021) · Nutrients · doi:10.3390/nu13062112 · Cited by 213
Lai, H., Li, Y., He, Y., Chen, F., Mi, B., Li, J., Xie, J., Ma, G., Yang, J., Xu, K., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2197837 · Cited by 208
Israelyan, N., Del Colle, A., Li, Z., Park, Y., Xing, A., Jacobsen, J. P. R., Luna, R. A., Jensen, D. D., Madra, M., Saurman, V., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.022 · Cited by 207
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
Zhao, L., Yang, W., Chen, Y., Huang, F., Lu, L., Lin, C., Huang, T., Ning, Z., Zhai, L., Zhong, L. L. D., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130976 · Cited by 202 · cited 3×
“Conversely, the overexpression of TGR5 results in diarrhea due to accelerating colonic transit in mice (Zhao et al., 2020a).”
Self-citationGut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
Zhang, L., Chu, J., Hao, W., Zhang, J., Li, H., Yang, C., Yang, J., Chen, X., & Wang, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/5110276 · Cited by 201 · cited 2×
“Recent structural insights reveal that CCK1 receptor conformational plasticity enables selective Gs/Gi/ Gq protein coupling, providing a molecular basis for developing gut-selective modulators (Zhang et al., 2021b).”
Diabetic Gastroparesis: Principles and Current Trends in Management
Krishnasamy, S., & Abell, T. L. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0454-9 · Cited by 199 · cited 1×
“Research indicates that 70% to 75% of diabetic individuals experience at least one GI symptom (Krishnasamy and Abell, 2018), with dysphagia (63%), gastroesophageal re fl ux (41%), early satiety or nausea (10% – 20%), constipation (60%), and diarrhea (20”
Disorders of the enteric nervous system — a holistic view
Niesler, B., Kuerten, S., Demir, I. E., & Schäfer, K.-H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00385-2 · Cited by 196 · cited 1×
“Analogous to the CNS, it integrates sensory neurons, interneurons, and motor neurons to form autonomous sensory-motor re fl ex arcs, which are the essential framework for the autonomous regulation of digestive tract functions (Niesler et al., 2021).”
Waller, P. A., Gopal, P. K., Leyer, G. J., Ouwehand, A. C., Reifer, C., Stewart, M. E., & Miller, L. E. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.584895 · Cited by 195
Li, N., Chen, H., Cheng, Y., Xu, F., Ruan, G., Ying, S., Tang, W., Chen, L., Chen, M., Lv, L., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759435 · Cited by 188
Iwasaki, M., Akiba, Y., & Kaunitz, J. D. (2019) · F1000Research · doi:10.12688/f1000research.18039.1 · Cited by 182 · cited 1×
“Beyond neuromodulation, VIP maintains intestinal immune homeostasis by regulating T-cell responses and TLR signaling, demonstrating therapeutic potential in neuroimmune disorders like T1DM and irritable bowel syndrome (Iwasaki et al., 2019).”
Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management
Du, Y. T., Rayner, C. K., Jones, K. L., Talley, N. J., & Horowitz, M. (2018) · Diabetes Care · doi:10.2337/dc17-1536 · Cited by 180
Ibrahim, A., Ali, R. A. R., Manaf, M. R. A., Ahmad, N., Tajurruddin, F. W., Qin, W. Z., Desa, S. H. M., & Ibrahim, N. M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0244680 · Cited by 174
The Gut Microbiome and Type 2 Diabetes Mellitus: Discussing A Complex Relationship
Sikalidis, A. K., & Maykish, A. (2020) · Biomedicines · doi:10.3390/biomedicines8010008 · Cited by 170
Bober, J. R., Beisel, C. L., & Nair, N. U. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121019 · Cited by 168
How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives
Campaniello, D., Corbo, M. R., Sinigaglia, M., Speranza, B., Racioppo, A., Altieri, C., & Bevilacqua, A. (2022) · Nutrients · doi:10.3390/nu14122456 · Cited by 167 · cited 1×
“Regular exercise, conversely, promotes bene fi cial bacteria proliferation, enhances intestinal barrier integrity, and maintains metabolic homeostasis (Campaniello et al., 2022).”
Dass, N. B., John, A. K., Bassil, A. K., Crumbley, C. W., Shehee, W. R., Maurio, F. P., Moore, G. B. T., Taylor, C. M., & Sanger, G. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00853.x · Cited by 166
Wu, Z., Zhang, B., Chen, F., Xia, R., Zhu, D., Chen, B., Lin, A., Zheng, C., Hou, D., Li, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1089991 · Cited by 158
Camilleri, M., McCallum, R. W., Tack, J., Spence, S. C., Gottesdiener, K., & Fiedorek, F. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.035 · Cited by 157
The Enteric Nervous System and Its Emerging Role as a Therapeutic Target
Fleming, M. A., Ehsan, L., Moore, S. R., & Levin, D. E. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/8024171 · Cited by 157 · cited 1×
“Novel approaches, including ghrelin receptor agonists, pyloric botulinum toxin injections, and surgical pyloromyotomy, show promise but necessitate thorough evaluation (Fleming et al., 2020; Schol et al., 2021).”
Quera, R., Espinoza, R., Estay, C., & Rivera, D. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.10.002 · Cited by 156
Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Kassam, Z., Sadovsky, R. G., Elliott, R. J., Budree, S., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30198-0 · Cited by 153
Pellegrini, S., Sordi, V., Bolla, A. M., Saita, D., Ferrarese, R., Canducci, F., Clementi, M., Invernizzi, F., Mariani, A., Bonfanti, R., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3222 · Cited by 152
Schol, J., Wauters, L., Dickman, R., Drug, V., Mulak, A., Serra, J., Enck, P., Tack, J., & the ESNM Gastroparesis Consensus Group (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12060 · Cited by 152
Camilleri, M., & Sanders, K. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.028 · Cited by 151
Pan, R., Wang, L., Xu, X., Chen, Y., Wang, H., Wang, G., Zhao, J., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14183704 · Cited by 149 · cited 1×
“Tao et al. 10.3389/fcimb.2025.1603442 Frontiers in Cellular and Infection Microbiology frontiersin.org including potentially pathogenic bacteria such as methanogenic bacteria , Desulfovibrionaceae , Escherichia coli , and Staphylococcus aureus (Pan et al., 2022).”
InfluentialGut microbiome and bile acids in obesity-related diseases
Li, R., Andreu-Sánchez, S., Kuipers, F., & Fu, J. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101493 · Cited by 147 · cited 4×
“…abundance of Akkermansia , Bacteroides , Bi fi dobacterium , Faecalibacterium , and Roseburia reduces b -glucuronidase and 7 a -dehydroxylase activities, thereby blocking the conversion of primary BAs to secondary BAs and consequently decreasing the synthesis of DCA and LCA (Li et al., 2021b).”
InfluentialSavarino, E., Zingone, F., Barberio, B., Marasco, G., Akyuz, F., Akpinar, H., Barboi, O., Bodini, G., Bor, S., Chiarioni, G., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12259 · Cited by 146
Pathophysiology of Type 1 Diabetes and Gut Microbiota Role
CHIERICO, F. D., Rapini, N., Deodati, A., Matteoli, M. C., Cianfarani, S., & Putignani, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314650 · Cited by 146 · cited 1×
“The gut microbiome, the most complex microecosystem in the digestive tract, plays a pivotal role in various physiological processes, such as nutrient absorption, glucose and lipid metabolism, immune regulation, and GI motility (Del Chierico et al., 2022).”
The intestine as an endocrine organ and the role of gut hormones in metabolic regulation
Bany Bakar, R., Reimann, F., & Gribble, F. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00830-y · Cited by 144
Vagal mediation of the cholecystokinin satiety effect in rats
LORENZ, D., & Goldman, S. A. (1982) · Physiology & Behavior · doi:10.1016/0031-9384(82)90226-8 · Cited by 142
McVey Neufeld, K. A., Perez‐Burgos, A., Mao, Y. K., Bienenstock, J., & Kunze, W. A. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12534 · Cited by 142 · cited 1×
“…release, while GABA_B receptors promote contraction by enhancing cholinergic signaling; in the duodenum, GABA_A receptors are involved in releasing ACh, and GABA_C receptors are associated with releasing NO (Tonini et al., 1989; Zizzo et al., 2007; Rotondo et al., 2010; Auteri et al., 2014, 2015).”
Sanders, K. M., & Ward, S. M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14459 · Cited by 139 · cited 1×
“…nNOS and NO levels, accompanied by disrupted connections between nNOS + neurons and SIP syncytia, leading to rhythmic disturbances in the jejunum, ileum, and colon, which is closely linked to gut microbiota dysbiosis (Bo ́ di et al., 2019; Sanders and Ward, 2019; Camilleri and Sanders, 2022).”
Understanding bile acid signaling in diabetes: From pathophysiology to therapeutic targets
Ferrell, J. M., & Chiang, J. Y. L. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0043 · Cited by 139
Yarandi, S. S., Kulkarni, S., Saha, M., Sylvia, K. E., Sears, C. L., & Pasricha, P. J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.050 · Cited by 138
Wang, C., Yen, H., Lu, W., Ho, H.-H., Lin, W., Kuo, Y., Huang, Y.-Y., Tsai, S., & Lin, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.754401 · Cited by 125
Ibarra, A., Latreille-Barbier, M., Donazzolo, Y., Pelletier, X., & Ouwehand, A. C. (2018) · Gut Microbes · doi:10.1080/19490976.2017.1412908 · Cited by 121
Müller, M., Hermes, G. D. A., Emanuel E., C., Holst, J. J., Zoetendal, E. G., Smidt, H., Troost, F., Schaap, F. G., Damink, S. O., Jocken, J. W. E., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1704141 · Cited by 120
Mokkala, K., Paulin, N., Houttu, N., Koivuniemi, E., Pellonperä, O., Khan, S., Pietilä, S., Tertti, K., Elo, L. L., & Laitinen, K. (2020) · Gut · doi:10.1136/gutjnl-2020-321643 · Cited by 120
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
GLP-1 and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk
Abdalqadir, N., & Adeli, K. (2022) · Microorganisms · doi:10.3390/microorganisms10102061 · Cited by 119
Lai, C. Y., Sung, J., Cheng, F., Tang, W., Wong, S. H., Chan, P. K. S., Kamm, M. A., Sung, J. J. Y., Kaplan, G., Chan, F. K. L., et al. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15116 · Cited by 118
Lelièvre, V., Favrais, G., Abad, C., Adle‐Biassette, H., Lu, Y., Germano, P. M., Cheung-Lau, G. C., Pisegna, J., Gressèns, P., Lawson, G. W., et al. (2007) · Peptides · doi:10.1016/j.peptides.2007.05.006 · Cited by 112 · cited 1×
“VIP is critical for preserving ENS function: VIP-de fi cient mice exhibit attenuated jejunal motility (Lelievre et al., 2007), and downregulated VIP expression correlates with severe constipation, indicating attenuated VIP signaling as a common pathological feature in dysmotility (Bai et al., 2023).”
Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders
Huaman, J.-W., Mego, M., Manichanh, C., Cañellas, N., Cañueto, D., Segurola, H., Jansana, M., Malagelada, C., Accarino, A., Vulevic, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.045 · Cited by 111
Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract
Bunnett, N. W. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.271155 · Cited by 110 · cited 1×
“On the contrary, in the colon, DCA and taurocholic acid could activate TGR5 on ECs and enteric neurons to stimulate the release of TPH1 and 5-HT, thus enhancing colonic motility (Bunnett, 2014).”
Type 2 diabetes and gut microbiome: at the intersection of known and unknown
Upadhyaya, S., & Banerjee, G. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1024918 · Cited by 109
Role of gut microbiota-derived signals in the regulation of gastrointestinal motility
Zheng, Z., Tang, J., Hu, Y., & Zhang, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.961703 · Cited by 103
Gut hormone co-agonists for the treatment of obesity: from bench to bedside
Nogueiras, R., Nauck, M. A., & Tschöp, M. H. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00812-z · Cited by 102
He, Q., Han, C., Huang, L., Yang, H., Hu, J., Chen, H., Dou, R., Ren, D., & Lin, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15586 · Cited by 101
Gut peptides and the microbiome: focus on ghrelin
Leeuwendaal, N. K., Cryan, J. F., & Schellekens, H. (2021) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000616 · Cited by 101
Sajdel, E. M. (2023) · Microorganisms · doi:10.3390/microorganisms11092199 · Cited by 101
López‐Moreno, A., Suárez, A., Avanzi, C., Monteoliva‐Sánchez, M., & Aguilera, J. (2020) · Nutrients · doi:10.3390/nu12071921 · Cited by 98
Chandrasekharan, B., Saeedi, B. J., Alam, A., Houser, M., Srinivasan, S., Tansey, M., Jones, R., Nusrat, A., & Neish, A. S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.045 · Cited by 94
Hiramoto, B., McCarty, T. R., Lodhia, N. A., Jenkins, A., Elnaiem, A., Muftah, M., Flanagan, R., & Chan, W. W. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002820 · Cited by 94
De Winter, B. Y. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i44.5523 · Cited by 92
Change in populations of macrophages promotes development of delayed gastric emptying in mice
Cipriani, G., Gibbons, S. J., Miller, K. E., Yang, D. S., Terhaar, M. L., Eisenman, S. T., Ördög, T., Linden, D. R., Gajdos, G. B., Szurszewski, J. H., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.027 · Cited by 88
Italian guidelines for the management of irritable bowel syndrome
Barbara, G., Cremon, C., Bellini, M., Corsetti, M., Nardo, G. D., Falangone, F., Fuccio, L., Galeazzi, F., Iovino, P., Sarnelli, G., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.11.015 · Cited by 88
He, Y., Wang, K., Su, N., Yuan, C., Zhang, N., Hu, X., Fu, Y., & Zhao, F. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70099 · Cited by 88 · cited 1×
“Furthermore, microbial metabolites such as SCFAs could regulate neurotransmitter production in enteric neurons through epigenetic modi fi cations (He et al., 2024b).”
Baudry, C., Reichardt, F., Marchix, J., Bado, A., Schemann, M., Varannes, S. B. D., Neunlist, M., & Moriez, R. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.219717 · Cited by 85
Lee, J., Cummings, B. P., Martin, E., Sharp, J. W., Graham, J. L., Stanhope, K. L., Havel, P. J., & Raybould, H. E. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00345.2011 · Cited by 84 · cited 1×
“This ultimately attenuates cholinergic neuron and vagal afferent activation ef fi ciency within the ENS (Lee et al., 2012).”
Tait, C., & Sayuk, G. S. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.12.023 · Cited by 84
Esmaili, A., Nazir, S. F., Borthakur, A., Yu, D., Turner, J. R., Saksena, S., Singla, A., Hecht, G. A., Alrefai, W. A., & Gill, R. K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.002 · Cited by 82
Aktar, R., Parkar, N., Stentz, R., Baumard, L., Parker, A., Goldson, A., Brion, A., Carding, S., Blackshaw, A., & Peiris, M. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1766936 · Cited by 80
Zeng, L., Yang, K., He, Q., Zhu, X., Long, Z., Wu, Y., Chen, J., Li, Y., Zeng, J., Cui, G., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03303-4 · Cited by 80
What is the role of endogenous gut serotonin in the control of gastrointestinal motility?
Keating, D. J., & Spencer, N. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.017 · Cited by 79
Karačić, A., Renko, I., Krznarić, Ž., Majanović, S. K., & Pršo, A.-M. L. (2024) · Biomedicines · doi:10.3390/biomedicines12102263 · Cited by 79
Neuron–Glia Interaction in the Developing and Adult Enteric Nervous System
Pawolski, V., & Schmidt, M. H. H. (2020) · Cells · doi:10.3390/cells10010047 · Cited by 78 · cited 1×
“The myenteric plexus, spanning the GI tract, coordinates smooth muscle contractions to propel luminal contents, whereas the submucosal plexus, localized to the small and large intestines, modulates secretion, absorption, and responses to chemical and mechanical stimuli (Pawolski and Schmidt, 2020).”
Gut Microbiota-Derived Short-Chain Fatty Acids: Novel Regulators of Intestinal Serotonin Transporter
Buey, B., Forcén, A., Grasa, L., Layunta, E., Mesonero, J. E., & Latorre, E. (2023) · Life · doi:10.3390/life13051085 · Cited by 76 · cited 1×
“5-HT 5-HT exerts its biological effects through speci fi c receptors, including 5-HT1, 5-HT2, 5-HT3, 5-HT4, and 5-HT7, with SCFAs modulating both serotonin transporter (SERT) activity and receptor expression pro fi les (Buey et al., 2023).”
Rokkas, T., Gisbert, J. P., Gasbarrini, A., Hold, G. L., Tilg, H., Malfertheiner, P., Mégraud, F., & O’Morain, C. A. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854587 · Cited by 75
Nitrergic Enteric Neurons in Health and Disease—Focus on Animal Models
Bódi, N., Szalai, Z., & Bagyánszki, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082003 · Cited by 74
Single-cell encapsulation systems for probiotic delivery: Armor probiotics
Zhao, R., Yu, T., Li, J., Niu, R., Liu, D., & Wang, W. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103270 · Cited by 74 · cited 1×
“…being investigated, including the use of bio fi lms and nanocoating for “ nano armor ” (Xu et al., 2022), single-cell technology-based “ armored probiotics ” (Zhao et al., 2024), targeted delivery systems (Li and Zhang, 2024), and encapsulating probiotics into microcapsules and microspheres using…”
Integrative Control of Gastrointestinal Motility by Nitric Oxide
Groneberg, D., Voußen, B., & Friebe, A. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160812150907 · Cited by 72 · cited 1×
“…iNOS), nNOS-positive neurons predominantly regulate smooth muscle tone via the NO-cGMP pathway, mediating relaxation of the lower esophageal sphincter, pyloric sphincter, and Oddi sphincter, as well as coordinating gastrointestinal peristaltic rhythms (Groneberg et al., 2016; Idrizaj et al., 2021).”
Schol, J., Wauters, L., Dickman, R., Drug, V., Mulak, A., Serra, J., Enck, P., Tack, J., & the ESNM Gastroparesis Consensus Group (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14237 · Cited by 71
Fecal microbiota transplantation in obesity metabolism: A meta analysis and systematic review
Zecheng, L., Donghai, L., Runchuan, G., Yuan, Q., Qi, J., Yijia, Z., Shuaman, R., Xiaoqi, L., Yi, W., Ni, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110803 · Cited by 69
Zhang, X., Tian, H., Gu, L., Nie, Y., Ding, C., Ge, X., Yang, B. K., Gong, J., & Li, N. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9229-1 · Cited by 67
Nitric Oxide: From Gastric Motility to Gastric Dysmotility
Idrizaj, E., Traini, C., Vannucchi, M. G., & Baccari, M. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189990 · Cited by 66
Zhou, H., Zhao, X. Y., Sun, L., Liu, Y., Lv, Y., Gang, X., & Wang, G. (2020) · Disease Markers · doi:10.1155/2020/3936247 · Cited by 65
The Alteration in Composition and Function of Gut Microbiome in Patients with Type 2 Diabetes
Zhao, X. Y., Zhang, Y., Guo, R., Yu, W., Zhang, F., Wu, F., & Shang, J. (2020) · Journal of Diabetes Research · doi:10.1155/2020/8842651 · Cited by 63 · cited 3×
“Conversely, the overexpression of TGR5 results in diarrhea due to accelerating colonic transit in mice (Zhao et al., 2020a).”
Gomi, A., Yamaji, K., Watanabe, O., Yoshioka, M., Miyazaki, K., Iwama, Y., & Urita, Y. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13803 · Cited by 60
Rouault, A. A. J., Rosselli‐Murai, L. K., Hernández, C. C., Gimenez, L. E., Tall, G. G., & Sebag, J. A. (2020) · Science Signaling · doi:10.1126/scisignal.aax4569 · Cited by 60 · cited 1×
“As a pivotal modulator of ENS and metabolic homeostasis, ghrelin activates growth hormone secretagogue receptor 1a (GHSR1a) to exert dual regulatory effects (Rouault et al., 2020).”
Structures of the human cholecystokinin receptors bound to agonists and antagonists
Zhang, X., He, C., Wang, M., Zhou, Q., Yang, D., Zhu, Y., Feng, W., Zhang, H., Dai, A., Chu, X., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00866-8 · Cited by 60 · cited 2×
“Recent structural insights reveal that CCK1 receptor conformational plasticity enables selective Gs/Gi/ Gq protein coupling, providing a molecular basis for developing gut-selective modulators (Zhang et al., 2021b).”
Changes in Nicotinic Neurotransmission during Enteric Nervous System Development
Foong, J. P. P., Hirst, C. S., Hao, M. M., McKeown, S. J., Boesmans, W., Young, H. M., Bornstein, J. C., & Berghe, P. V. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4175-14.2015 · Cited by 56
Ono, S., Karaki, S.-I., & Kuwahara, A. (2004) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.54.483 · Cited by 55
Topological segregation of stress sensors along the gut crypt–villus axis
Touhara, K. K., Rossen, N. D., Deng, F., Castro, J., Harrington, A. M., Chu, T., Garcia‐Caraballo, S., Brizuela, M., O’Donnell, T. A., Xu, J., et al. (2025) · Nature · doi:10.1038/s41586-024-08581-9 · Cited by 55 · cited 1×
“…autonomic terminals, mediate distinct effects: 5-HT4 activation evokes acetylcholine release from cholinergic neurons, enhancing smooth muscle contraction (Pauwelyn and Lefebvre, 2017), whereas 5-HT3 sensitization of afferent nerves regulates motility rhythms and secretory (Touhara et al., 2025).”
Role of 5‐HT in the enteric nervous system and enteroendocrine cells
Spencer, N. J., & Keating, D. J. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15930 · Cited by 54
Kang, S., Park, M. Y., Brooks, I., Lee, J., Kim, S. H., Kim, J. Y., Oh, B., Kim, J. W., & Kwon, O. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110428 · Cited by 53
Li, X., Feng, X., & Li, X. (2022) · Aging · doi:10.18632/aging.203854 · Cited by 53
Yang, M., Fukui, H., Eda, H., Xu, X., Kitayama, Y., Hara, K., Kodani, M., Tomita, T., Oshima, T., Watari, J., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00232.2016 · Cited by 52
He, L., Zhong, Z., Wen, S., Li, P., Jiang, Q., & Liu, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01588-9 · Cited by 52
Diabetic gastroenteropathy: An underdiagnosed complication
Concepción Zavaleta, M. J., Gonzáles Yovera, J. G., Moreno Marreros, D. M., Rafael Robles, L. D. P., Palomino Taype, K. R., Soto Gálvez, K. N., Arriola Torres, L. F., Coronado Arroyo, J. C., & Concepción Urteaga, L. A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.794 · Cited by 51
Ahmed, K., Choi, H., Cho, S.-R., & Yim, J. (2024) · Metabolites · doi:10.3390/metabo14100518 · Cited by 51
The regulation of gastric ghrelin secretion
Nunez‐Salces, M., Li, H., Feinle‐Bisset, C., Young, R. L., & Page, A. J. (2020) · Acta Physiologica · doi:10.1111/apha.13588 · Cited by 49 · cited 1×
“Centrally, it stimulates neuropeptide Y (NPY) neurons and vagal afferents to coordinate feeding behavior and glucose metabolism (Nunez-Salces et al., 2021).”
Engineered 5-HT producing gut probiotic improves gastrointestinal motility and behavior disorder
Li, B., Li, M., Luo, Y., Li, R., Li, W., & Liu, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1013952 · Cited by 49
Russo, F., Clemente, C., Linsalata, M., Chiloiro, M., Orlando, A., Marconi, E., Chimienti, G., & Riezzo, G. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0135-6 · Cited by 47
Brun, P., Scarpa, M., Marchiori, C., Sarasin, G., Caputi, V., Porzionato, A., Giron, M. C., Palù, G., & Castagliuolo, I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181863 · Cited by 47
Taverniti, V., Cesari, V., Gargari, G., Rossi, U., Biddau, C., Lecchi, C., Fiore, W., Arioli, S., Toschi, I., & Guglielmetti, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.706135 · Cited by 47
Banerjee, S., Poore, M., Gerdes, S., Nedveck, D. A., Lauridsen, L., Kristensen, H. T., Jensen, H. M., Byrd, P. M., Ouwehand, A. C., Patterson, E., et al. (2021) · Microbial Cell Factories · doi:10.1186/s12934-021-01658-4 · Cited by 47
Du, Y., Qiongli, N., Li, Y., Kang, Y., Guo, L., Huang, X., Chen, M., Yang, F., Hong, J., Zhou, S., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.804733 · Cited by 47 · cited 2×
“Enrichment of Proteobacteria represents one of the most prominent microbiota features in DGE, with increased abundance positively correlating with the progression of DGE (Du et al., 2022).”
Self-citationWang, Y., Lin, J., Cheng, Z., Wang, T., Chen, J., & Long, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5463290 · Cited by 45
Enteric neuropathy in diabetes: Implications for gastrointestinal function
Abdalla, M. M. I. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i22.2852 · Cited by 45
Guo, Y., Song, L., Huang, Y., Li, X., Xiao, Y., Wang, Z., & Ren, Z. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1039403 · Cited by 44
Hung, L. Y., Parathan, P., Boonma, P., Wu, Q., Wang, Y., Haag, A., Luna, R. A., Bornstein, J. C., Savidge, T. C., & Foong, J. P. P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00088.2020 · Cited by 43
Fecal microbiota transplantation alters the susceptibility of obese rats to type 2 diabetes mellitus
Zhang, L., Zhou, W., Zhan, L., Hou, S., Zhao, C., Bi, T., & Lu, X. (2020) · Aging · doi:10.18632/aging.103756 · Cited by 43
Bai, X., Palma, G. D., Boschetti, E., Nishiharo, Y., Lu, J. G., Shimbori, C., Costanzini, A., Saqib, Z., Kraïmi, N., Sidani, S., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.11.012 · Cited by 43
Physiology of γ-aminobutyric acid production by Akkermansia muciniphila
Konstanti, P., Ligthart, K., Fryganas, C., Patinios, C., Smidt, H., de Vos, W. M., & Belzer, C. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.01121-23 · Cited by 43
Distribution and Stimulus Secretion Coupling of Enteroendocrine Cells along the Intestinal Tract
Adriaenssens, A. E., Reimann, F., & Gribble, F. M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170047 · Cited by 41
Camilleri, M., & Lupianez-Merly, C. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002519 · Cited by 41
Influence of selective VIP receptor agonists in the rat gastric fundus
Robberecht, P., NEEF, P. D., & Lefebvre, R. A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00662-1 · Cited by 39
Tonini, M., Crema, A., Frigo, G. M., Rizzi, C. A., Manzo, L., Candura, S. M., & Onori, L. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb12654.x · Cited by 38
Dixon, S. A., Mishra, S. P., DIETSCHE, K. B., Jain, S., Mabundo, L. S., Stagliano, M. S., Krenek, A. M., Courville, A. B., Yang, S. B., Turner, S. A., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125187 · Cited by 38
Fung, C., Unterweger, P., Parry, L. J., Bornstein, J. C., & Foong, J. P. P. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00416.2013 · Cited by 37
Lim, Y. J., Jamaluddin, R., Hazizi, A. S., & Chieng, J. Y. (2018) · Nutrients · doi:10.3390/nu10070824 · Cited by 37
Hata, S., Nakajima, H., Hashimoto, Y., Miyoshi, T., Hosomi, Y., Okamura, T., Majima, S., Nakanishi, N., Senmaru, T., Osaka, T., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13698 · Cited by 36
Gut Metagenome as a Potential Diagnostic and Predictive Biomarker in Slow Transit Constipation
Tian, H., Ye, C., Yang, B. K., Cui, J., Zheng, Z., Wu, C., Zhou, S., Lv, X., Qin, N., Qin, H., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.777961 · Cited by 36
Guo, L., Chen, Q., Gao, Y., Jiang, H., Zhou, F., Zhang, F., & Xu, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115845 · Cited by 35
Zizzo, M. G., Mulè, F., & Serio, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.016 · Cited by 34
Clinical Efficacy and Prokinetic Effect of the CCK‐A Antagonist Loxiglumide in Nonulcer Dyspepsia
Chua, A., Bekkering, M., Rovati, L. C., & Keeling, P. W. N. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44124.x · Cited by 33
Cheng, S., Li, H., Ding, Y., Huo, J., Zheng, Y., Jiang, Y., Zhang, Y., & Man, C. (2023) · Nutrients · doi:10.3390/nu15040839 · Cited by 33
Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
Darra, A., Singh, V., Jena, A., Popli, P., Nada, R., Gupta, P. C., Bhadada, S. K., Singh, A. K., Sharma, V., Bhattacharya, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-37720-x · Cited by 32 · cited 1×
“This compromised barrier facilitates the translocation of harmful microorganisms, such as Escherichia coli , from the gut lumen into systemic circulation, thereby exacerbating systemic in fl ammation (Darra et al., 2023).”
Doong, M., Lu, C., Kau, M., Tsai, S.-C., Chiao, Y., Chen, J.-J., Yeh, J., Lin, H., Huang, S., Chen, T., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701937 · Cited by 30
Association of the gut microbiota with clinical variables in obese and lean Emirati subjects
Ahmad, M. A., Karavetian, M., Moubareck, C. A., Wazz, G., Mahdy, T., & Venema, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1182460 · Cited by 30
Guardians of the gut: influence of the enteric nervous system on the intestinal epithelial barrier
Bubeck, M., Becker, C., & Patankar, J. V. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1228938 · Cited by 30 · cited 1×
“It also alters the structure and signaling of the ENS by inducing myenteric plexitis, neuronal hyperplasia, and neuropeptide dysregulation (Bubeck et al., 2023).”
Tang, N., Yu, Q., Mei, C., Wang, J., Wang, L., Wang, G., Zhao, J., & Chen, W. (2023) · Nutrients · doi:10.3390/nu15051146 · Cited by 29
Auteri, M., Zizzo, M. G., Mastropaolo, M., & Serio, R. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.003 · Cited by 28 · cited 1×
“…release, while GABA_B receptors promote contraction by enhancing cholinergic signaling; in the duodenum, GABA_A receptors are involved in releasing ACh, and GABA_C receptors are associated with releasing NO (Tonini et al., 1989; Zizzo et al., 2007; Rotondo et al., 2010; Auteri et al., 2014, 2015).”
D’Amico, V., Lopalco, A., Iacobazzi, R. M., Vacca, M., Siragusa, S., Angelis, M. D., Lopedota, A., & Denora, N. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124223 · Cited by 27
Zhou, L., Wei, S., Liu, T., Yan, T., He, Z., He, W., Lv, J., Zhang, S., Dai, X., Li, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134860 · Cited by 27
Li, S., & Zhang, Y.-X. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2202237 · Cited by 26
Wang, L., Lv, W., Yang, J., Xu, L., Li, H., Tan, H.-J., Quan, R., Long, P.-P., Shen, H., Shen, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1117905 · Cited by 26
Talamantes, S., Steiner, F., Spencer, S. P., Neshatian, L., & Sonu, I. S. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08563-x · Cited by 26
Tulk, H., Blonski, D. C., Murch, L. A., Duncan, A. M., & Wright, A. J. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-87 · Cited by 25
Microbiota-derived acetylcholine can promote gut motility in Drosophila melanogaster
Fujita, Y., Kosakamoto, H., & Obata, F. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2023.0075 · Cited by 25
Lee, J., Kim, G., Han, K., Jung, E.-J., Suh, H. J., & Jo, K. (2024) · Food & Function · doi:10.1039/d4fo00999a · Cited by 24
The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases
Eslami, M., Alibabaei, F., Babaeizad, A., Banihashemian, S. Z., Mazandarani, M., Hoseini, A., Ramezankhah, M., Oksenych, V., & Yousefi, B. (2024) · Biomolecules · doi:10.3390/biom14111345 · Cited by 24 · cited 1×
“…c strains (e.g., Lactobacillus plantarum Lsi ) secrete ACh-like compounds, directly enhancing intestinal contractions (Fujita et al., 2024); conversely, trimethylamine (TMA)-producing Firmicutes and Proteobacteria metabolize dietary choline, depleting ACh synthesis substrates (Eslami et al., 2024).”
Gurley, B. J., Miousse, I. R., Nookaew, I., Ewing, L., Skinner, C. M., Jenjaroenpun, P., Wongsurawat, T., Kennon‐McGill, S., Avula, B., Bae, J.-Y., et al. (2019) · Nutrients · doi:10.3390/nu11040776 · Cited by 23
Xu, Y., Cao, K., Guo, B., Xiang, J., Dong, Y., Qi, X., Yu, W., Xiao, Y. C., & Guan, Z. (2020) · Aging · doi:10.18632/aging.103435 · Cited by 23
Intestinal microbiota and antibiotic-associated acute gastrointestinal injury in sepsis mice
Han, C., Guo, N., Bu, Y., Peng, Y., Li, X., Ma, X., Yang, M., Jia, X., Zhang, J., Liu, X., et al. (2021) · Aging · doi:10.18632/aging.202768 · Cited by 22
Ohtsu, T., Haruma, K., Ide, Y., & Takagi, A. (2021) · Nutrients · doi:10.3390/nu13061852 · Cited by 21
Wu, Y., Li, S., Lv, L., Jiang, S., Xu, L., Chen, H., & Li, L. (2024) · Food & Function · doi:10.1039/d3fo04904c · Cited by 21 · cited 1×
“Kang et al. (2021); Cheng et al., 2023; Lai et al., 2023; Wu et al., 2024; Zhou et al., 2024; Wang et al., 2025) demonstrated that Lactobacillales and Synergistales exhibit negative and positive correlations with colonic transit time, respectively; however, the regulation of the…”
Leptin excites enteric neurons of guinea-pig submucous and myenteric plexus
Reichardt, F., Krueger, D., & Schemann, M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01665.x · Cited by 20 · cited 1×
“Notably, although leptin excites submucosal and myenteric neurons, it does not directly stimulate GI muscular activity but instead potentiates CCK-mediated intestinal propulsion (Reichardt et al., 2011).”
IgM-associated gut bacteria in obesity and type 2 diabetes in C57BL/6 mice and humans
Pearson, J. A., Ding, H., Hu, C., Peng, J., Galuppo, B., Wong, F. S., Caprio, S., Santoro, N., & Li, W. (2022) · Diabetologia · doi:10.1007/s00125-022-05711-8 · Cited by 20
Huang, Y., Guo, Y., Li, X., Xiao, Y., Wang, Z., Song, L., & Ren, Z. (2023) · Nutrients · doi:10.3390/nu15173741 · Cited by 20
Research works printed but not linked: 1
- Gershon, 1998, The Second Brain : The Scientific Basis of Gut Instinct and a Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestines
Cited by
Beyond Digestion: The Gut Microbiota as an Immune–Metabolic Interface in Disease Modulation
Mohammad, I., Ansari, M. R., Khan, M. S., Bari, M. N., Kamal, M. A., & Poyil, M. M. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7040077 · Cited by 31
“These compounds can directly or indirectly affect neurotransmission, mood, and cognitive processes [69].”
Role of traditional Chinese medicine in combating metabolic disorders: A systematic review
Pathak, A., Agrawal, M., Sethi, P., Sahu, K. K., Sharma, M., Chaudhary, H., Kumar, D., Singh, T. G., & Kumar, M. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100703 · Cited by 4
Protective Effects of PACAP in Diabetic Complications: Retinopathy, Nephropathy and Neuropathy
Reglődi, D., Tamás, A., Bosnyák, I., Atlasz, T., Szabo, E., Li, L., Horváth, G., Opper, B., Kiss, P., Lucas, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199650 · Cited by 3
“Diabetic gastroenteropathy is another common complication [214,215], and a study in diabetic pigs showed that PACAP-containing enteric neurons reacted sensitively to altered conditions, as immunoreactivity strongly increased in the small intestine, descending colon and stomach [216].”
Shukla, A., Yadav, M., Malik, M. Z., Aditya, A. K., Kumar, A., Tandon, R., Shalimar, & Ray, A. K. (2026) · 3 Biotech · doi:10.1007/s13205-025-04675-x · Cited by 2
“We observed that the oxidative phosphorylation (OXPHOS) pathway was highly enriched in the rural group, while”
Khan, Z., Khan, T., Khan, F., & Bashir, B. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014864 · Cited by 2
Metadata
- Authors
- Tao, W., Yu, Y., Tan, D., Huang, X., Huang, J., Lin, C., & Yu, R.
- Affiliations
- Hunan University of Traditional Chinese Medicine (CN)
- Guangzhou University of Chinese Medicine (CN)
- Corresponding author
- Yu, Rong
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2025-08-11
- Volume
- 15
- Pages
- 1603442-1603442
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC12375670
- OpenAlex
- W4413227848
- Cited by
- 9
- References
- 226
- Citations by year
- 2026: 6 · 2025: 3
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
- National Natural Science Foundation of China ([82330078])
- Natural Science Foundation of Hunan Province
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- enteric nervous system, gut microbiota, dysbiosis, short-chain fatty acids, bile acids, tryptophan metabolites, gastrointestinal hormones, glucagon-like peptide-1, ghrelin, neurotransmitters, acetylcholine, vasoactive intestinal peptide, nitric oxide, autonomic neuropathy, vagus nerve, gastrointestinal motility, probiotics, prebiotics, fecal microbiota transplantation, microbiota-based therapy
- MeSH terms
- Gastrointestinal Microbiome, Animals, Gastrointestinal Diseases, Humans, Enteric Nervous System, Diabetes Complications, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.